Vildagliptin, an Anti-diabetic Drug of the DPP-4 Inhibitor, Induces Vasodilation via Kv Channel and SERCA Pump Activation in Aortic Smooth Muscle
Author:
Funder
National Research Foundation of Korea
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Link
http://link.springer.com/content/pdf/10.1007/s12012-018-9496-5.pdf
Reference37 articles.
1. Ogurtsova, K., da J. D. Fernandes, Huang, Y., et al. (2017). IDF diabetes atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Research and Clinical Practice, 128, 40–50.
2. Clemens, K. K., Shariff, S., Liu, K., et al. (2015). Trends in antihyperglycemic medication prescriptions and hypoglycemia in older adults: 2002–2013. PLoS ONE, 10, e0137596.
3. McIntosh, C. H., Demuth, H. U., Pospisilik, J. A., et al. (2005). Dipeptidyl peptidase IV inhibitors: How do they work as new antidiabetic agents? Regulatory Peptides, 128, 159–165.
4. van Poppel, P. C., Netea, M. G., Smits, P., et al. (2011). Vildagliptin improves endothelium-dependent vasodilatation in type 2 diabetes. Diabetes Care, 34, 2072–2077.
5. Nelson, M. T., & Quayle, J. M. (1995). Physiological roles and properties of potassium channels in arterial smooth muscle. American Journal of Physiology, 268(4 Pt 1), C799–C822.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Vasorelaxant mechanisms of the antidiabetic anagliptin in rabbit aorta: roles of Kv channels and SERCA pump;Acta Diabetologica;2024-08-06
2. The anti-diabetic drug trelagliptin induces vasodilation via activation of Kv channels and SERCA pumps;Life Sciences;2021-10
3. The anti-diabetic drug alogliptin induces vasorelaxation via activation of Kv channels and SERCA pumps;European Journal of Pharmacology;2021-05
4. Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection;Heart Failure Reviews;2020-07-21
5. Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis;International Journal of Molecular Sciences;2020-03-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3